Showing results (171-180 of 314) with videos related to
Sort By:
Pageof 32
International Journal of Cancer|September 3, 2020
Mutations in ATM, NBN and BRCA2 predispose to aggressive prostate cancer in PolandDominika Wokołorczyk, Wojciech Kluźniak, Tomasz Huzarski, et al.Hereditary Cancer in Clinical Practice|June 11, 2026
Association analysis of germline variants in GEN1 with a susceptibility to prostate cancer in Polish menKatarzyna Gliniewicz, Klaudia Stempa, Dominika Wokołorczyk, et al.Biomedicines|July 29, 2025
Blood Lead (Pb) Levels as a Possible Marker of Cancer Risk in a Prospective Cohort of Women with Non-Occupational ExposureKrzysztof Lubiński, Marcin R Lener, Wojciech Marciniak, et al.International Journal of Molecular Sciences|July 12, 2025
Analysis of GEN1 as a Breast Cancer Susceptibility Gene in Polish WomenKatarzyna Gliniewicz, Dominika Wokołorczyk, Wojciech Kluźniak, et al.International Journal of Cancer|October 31, 2009
CHEK2 mutations and HNPCC-related colorectal cancerJanina Suchy, Cezary Cybulski, Dominika Wokołorczyk, et al.Plos One|January 15, 2019
Iron levels, genes involved in iron metabolism and antioxidative processes and lung cancer incidenceGrzegorz Mariusz Sukiennicki, Wojciech Marciniak, Magdalena Muszyńska, et al.Cancer Research and Treatment|May 17, 2018
Founder Mutations for Early Onset Melanoma as Revealed by Whole Exome Sequencing Suggests That This is Not Associated with the Increasing Incidence of Melanoma in PolandTadeusz Dębniak, Rodney J Scott, Rodney A Lea, et al.Nutrients|February 24, 2024
Correlation between Selenium and Zinc Levels and Survival among Prostate Cancer PatientsSandra Pietrzak, Wojciech Marciniak, Róża Derkacz, et al.Cancers|July 20, 2021
Blood Arsenic Levels as a Marker of Breast Cancer Risk among BRCA1 CarriersWojciech Marciniak, Tomáš Matoušek, Susan Domchek, et al.Plos One|October 5, 2018
BRCA1/2 mutations are not a common cause of malignant melanoma in the Polish populationTadeusz Dębniak, Rodney J Scott, Bohdan Górski, et al.Pageof 32